Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine using the national adverse event following immunization surveillance system from Zhejiang province, 2018-2020

Adverse Event Following Immunization ◽

Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009–2015

Vaccine ◽

10.1016/j.vaccine.2018.02.034 ◽

2018 ◽

Vol 36 (13) ◽

pp. 1781-1788 ◽

Cited By ~ 23

Author(s):

Jorge E. Arana ◽

Theresa Harrington ◽

Maria Cano ◽

Paige Lewis ◽

Adamma Mba-Jonas ◽

...

Keyword(s):

Adverse Event ◽

Human Papillomavirus ◽

Reporting System ◽

Safety Monitoring ◽

Adverse Event Reporting ◽

Event Reporting ◽

Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database

Immunologic Research ◽

10.1007/s12026-016-8815-9 ◽

2016 ◽

Vol 65 (1) ◽

pp. 46-54 ◽

Cited By ~ 28

Author(s):

David A. Geier ◽

Mark R. Geier

Keyword(s):

Adverse Event ◽

Human Papillomavirus ◽

Adverse Events ◽

Reporting System ◽

Case Control ◽

Adverse Event Reporting ◽

Event Reporting ◽

2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017

Open Forum Infectious Diseases ◽

10.1093/ofid/ofy210.2116 ◽

2018 ◽

Vol 5 (suppl_1) ◽

pp. S738-S738 ◽

Cited By ~ 1

Author(s):

Jorge Arana ◽

John Su ◽

Paige Lewis ◽

Maria Cano ◽

Lauri E Markowitz ◽

...

Keyword(s):

United States ◽

Adverse Event ◽

Human Papillomavirus ◽

Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

Human Papillomavirus Vaccine Safety in Pediatric Patients: An Evaluation of the Vaccine Adverse Event Reporting System

Annals of Pharmacotherapy ◽

10.1345/aph.1l492 ◽

2009 ◽

Vol 43 (2) ◽

pp. 356-359 ◽

Cited By ~ 8

Author(s):

Nancy L Borja-Hart ◽

Sandra Benavides ◽

Crystal Christensen

Keyword(s):

Adverse Event ◽

Human Papillomavirus ◽

Pediatric Patients ◽

Reporting System ◽

Vaccine Safety ◽

Adverse Event Reporting ◽

Event Reporting ◽

Safety of quadrivalent human papillomavirus vaccine (Gardasil®) in pregnancy: Adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006–2013

Vaccine ◽

10.1016/j.vaccine.2014.11.047 ◽

2015 ◽

Vol 33 (4) ◽

pp. 519-522 ◽

Cited By ~ 18

Author(s):

Pedro L. Moro ◽

Yenlik Zheteyeva ◽

Paige Lewis ◽

Jing Shi ◽

Xin Yue ◽

...

Keyword(s):

Adverse Event ◽

Human Papillomavirus ◽

Adverse Events ◽

Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

Papillomavirus Vaccine ◽

In Pregnancy

Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States

JAMA Network Open ◽

10.1001/jamanetworkopen.2021.24502 ◽

2021 ◽

Vol 4 (9) ◽

pp. e2124502

Author(s):

Kalyani Sonawane ◽

Yueh-Yun Lin ◽

Haluk Damgacioglu ◽

Yenan Zhu ◽

Maria E. Fernandez ◽

...

Keyword(s):

United States ◽

Adverse Event ◽

Human Papillomavirus ◽

Vaccine Safety ◽

The United States ◽

Adverse Event Reporting ◽

Event Reporting ◽

Safety Concerns ◽

Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13736 ◽

2018 ◽

Vol 84 (12) ◽

pp. 2928-2932 ◽

Cited By ~ 10

Author(s):

Tiffany A. Suragh ◽

Paige Lewis ◽

Jorge Arana ◽

Adamma Mba-Jonas ◽

Rongxia Li ◽

...

Keyword(s):

Adverse Event ◽

Human Papillomavirus ◽

Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The Us ◽

Safety of 9-valent human papillomavirus vaccine administration among pregnant women: Adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014–2017

Vaccine ◽

10.1016/j.vaccine.2018.11.077 ◽

2019 ◽

Vol 37 (9) ◽

pp. 1229-1234 ◽

Cited By ~ 1

Author(s):

Claudia S. Landazabal ◽

Pedro L. Moro ◽

Paige Lewis ◽

Saad B. Omer

Keyword(s):

Adverse Event ◽

Human Papillomavirus ◽

Pregnant Women ◽

Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

Vaccine Administration ◽

Postlicensure surveillance of human papillomavirus vaccine using the Vaccine Adverse Event Reporting System, 2006–2017

Perspectives in Clinical Research ◽

10.4103/picr.picr_140_18 ◽

2020 ◽

Vol 11 (1) ◽

pp. 24 ◽

Cited By ~ 2

Author(s):

Viswam Subeesh ◽

Reddy Neha ◽

Elsa Beulah ◽

Nair Gouri ◽

Eswaran Maheswari

Keyword(s):

Adverse Event ◽

Human Papillomavirus ◽

Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

Human medicines European public assessment report (EPAR): Cervarix, human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Immunization, Date of authorisation: 20/09/2007, Revision: 32, Status: Authorised

Case Medical Research ◽

10.31525/cmr-145d596 ◽

2019 ◽

Author(s):

Keyword(s):

Human Papillomavirus ◽

Cervical Dysplasia ◽

Papillomavirus Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Papillomavirus Vaccine ◽

Uterine Cervical Dysplasia